The briefing
A University of Pittsburgh–led trial published in The Lancet Diabetes & Endocrinology suggests that newer insulin analogs may reduce low blood sugar episodes in young people with type 1 diabetes. The findings inform ongoing debates about analogs versus older human insulins, especially in low-resource settings.
Original headline
Newer insulin may reduce low blood sugar in youth with type 1 diabetes